Investigation of immune responses to SLA-derived antigens presented on HLA class II
Authors
Affiliations
Abstract
Background/Objectives: In xenotransplantation, identifying the xenoantigens that trigger potent indirect T-cell responses remains a critical challenge, whereas in allotransplantation, these responses and the resulting de novo donor-specific antibodies (DSAs) are well-known barriers to long-term survival. Although ten-gene-modified pigs have entered clinical study phases, the immunological significance of swine T-cell epitopes has not been fully elucidated. This study aimed to identify swine-derived peptide epitopes presented by human HLA class II molecules using ligandome analysis to clarify their role in xenograft immunity.
Methods: CD14+ monocytes were purified from human peripheral blood and differentiated into dendritic cells by adding IL-4, GM-CSF, IL-1β, and TNF-α in the presence of irradiated porcine liver-derived endothelial cell triple-gene knockout (GGTA1/CMAH/β4galNT2). Immunoprecipitation was performed using anti-HLA-DR antibodies, followed by mass spectrometry via nanoLC-qTOF/MS/MS to comprehensively analyze the presented peptides. The obtained peptides were synthesized and co-cultured with PBMCs from healthy individuals, and the production of IFN-γ and IL-21 was measured using the ELISPOT assay.
Results: On average, 608 swine-derived peptides corresponding to 197 antigens were identified. Among them, three peptides derived from swine leukocyte antigen (SLA), FIAVGYDDTQFVR (SLA-2), GVSETVFLPR (SLA-DRA1), and FDSDVGSFR (SLA-DQB1), were consistently detected across different samples. When we confirmed the ELISPOT response of peptides derived from the obtained SLA-derived peptides in healthy human PBMCs, T-cell responses were observed in multiple samples, although individual differences were noted.
Discussion: While some DSAs pose a high risk due to cross-reactivity with SLA, there is a possibility that porcine organ transplantation could induce novel indirect T-cell responses against SLA even in DSA-negative recipients. Our findings show that SLA-derived peptides are presented by human HLA class II and recognized by T cells, suggesting their role in xenograft immunity. These epitopes may be targets for genome editing to improve graft survival.